Apigenin suppresses proliferation, invasion, and epithelial–mesenchymal transition of cervical carcinoma cells by regulation of miR‐152/BRD4 axis
Open Access
- 20 February 2021
- journal article
- research article
- Published by Wiley in The Kaohsiung Journal of Medical Sciences
- Vol. 37 (7), 583-593
- https://doi.org/10.1002/kjm2.12370
Abstract
The present study aimed to investigate the role of apigenin and the molecular mechanism of miR‐152‐5p and bromodomain containing 4 (BRD4) in the proliferation, invasion, and epithelial–mesenchymal transition (EMT) of cervical carcinoma cells. Quantitative real‐time PCR was used to detect the transfection efficiency and the expression of miR‐152‐5p and BRD4. Western blotting was conducted to evaluate the protein level of BRD4, E‐cadherin, N‐cadherin, and MMP9. Luciferase reporter assay was performed to confirm whether miR‐152‐5p bound to BRD4. MTT and Transwell invasion assay were applied to determine the cell proliferation and invasion, respectively. MiR‐152‐5p was downregulated and BRD4 was upregulated in cervical carcinoma tissue. Besides, miR‐152‐5p could directly bind to BRD4 in Hela and CaSki cells. In addition, apigenin inhibited proliferation, invasion, and EMT of Hela and CaSki cells by regulating miR‐152‐5p/BRD4 axis. Apigenin suppresses proliferation, invasion, and induced EMT of cervical carcinoma cells by regulation of miR‐152‐5p/BRD4 axis.Keywords
This publication has 38 references indexed in Scilit:
- miR-152 as a tumor suppressor microRNA: Target recognition and regulation in cancerOncology Letters, 2016
- miR-152 functions as a tumor suppressor in colorectal cancer by targeting PIK3R3Tumor Biology, 2016
- MicroRNA-125a-5p modulates human cervical carcinoma proliferation and migration by targeting ABL2Drug Design, Development and Therapy, 2015
- Hypoxia-inducible miR-152 suppresses the expression of WNT1 and ERBB3, and inhibits the proliferation of cervical cancer cellsExperimental Biology and Medicine, 2015
- Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinomaTumor Biology, 2015
- BRD4 promotes tumor growth and epithelial-mesenchymal transition in hepatocellular carcinomaInternational Journal of Immunopathology and Pharmacology, 2015
- Apigenin inhibits HeLa sphere-forming cells through inactivation of casein kinase 2αMolecular Medicine Reports, 2014
- Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancerGynecologic Oncology, 2012
- Cross-talk Among RNA Polymerase II Kinases Modulates C-terminal Domain PhosphorylationOnline Journal of Public Health Informatics, 2012
- BRD4 is an atypical kinase that phosphorylates Serine2 of the RNA Polymerase II carboxy-terminal domainProceedings of the National Academy of Sciences of the United States of America, 2012